Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | FLT3 |
| Variant | V491L |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | FLT3 V491L lies within the extracellular domain of the Flt3 protein (UniProt.org). V491L has been identified in the scientific literature (PMID: 41487332, PMID: 37680325, PMID: 38502195), but has not been biochemically characterized and therefore, its effect on Flt3 protein function is unknown (PubMed, Apr 2026). |
| Associated Drug Resistance | |
| Category Variants Paths |
FLT3 mutant FLT3 V491L |
| Transcript | NM_004119.3 |
| gDNA | chr13:g.28035621C>G |
| cDNA | c.1471G>C |
| Protein | p.V491L |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_004119.3 | chr13:g.28035621C>G | c.1471G>C | p.V491L | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| FLT3 V491L | acute myeloid leukemia | sensitive | Gilteritinib | Case Reports/Case Series | Actionable | In a clinical case study, Xospata (gilteritinib) treatment resulted in disappearance of peripheral blasts in a patient with acute myeloid leukemia harboring FLT3 V491L, and in a preclinical study, inhibited viability of patient-derived acute myeloid leukemia cells in culture (PMID: 41487332). | 41487332 |